Toward Precision Neuropsychiatry of Dementia: Neuropsychiatric Symptoms as Multidimensional Clinical Phenotypes
- 17 August 2026
- journal article
- review article
- Published by Wiley in Psychogeriatrics
- Vol. 26 (5) , e70209
Abstract
Neuropsychiatric symptoms (NPS) are the most clinically consequential manifestations of dementia, yet they are frequently underestimated as secondary behavioural complications. This review introduces a precision neuropsychiatry framework that conceptualises NPS—including apathy, agitation, psychosis, depression, and sleep disturbances—as multidimensional clinical phenotypes. These phenotypes bridge neurodegeneration, biological aging, brain network disruption, psychosocial context, functional decline, and caregiver burden. We trace the conceptual evolution from dementia to neurocognitive disorders, and from behavioural and psychological symptoms of dementia (BPSD) to NPS and mild behavioural impairment (MBI). Precision neuropsychiatry stratifies NPS based on disease background, clinical stage, neural networks, biological aging, physical vulnerability, and psychosocial context to optimise differential diagnosis, prognostic prediction, and targeted interventions. Although conventional symptom‐based classification remains practically useful, it must be complemented by biological, functional, and contextual stratification; identical symptom labels often arise from distinct mechanisms and express differently based on personality, life history, environmental mismatch, and available resources. Emerging evidence from MBI, neuroimaging, brain‐age paradigms, frailty, neuroinflammation, Alzheimer's disease (AD) biomarkers, and international consensus criteria supports this multidimensional shift. Future research should advance from cross‐sectional symptom descriptions toward longitudinal, mechanism‐informed, and context‐sensitive models to translate these findings into real‐world psychogeriatric care.Keywords
Funding Information
- Japan Society for the Promotion of Science (24K10690)
- Japan Agency for Medical Research and Development (JP24wm0625505)
This publication has 48 references indexed in Scilit:
- Neuropsychiatric symptoms in Alzheimer's disease: Past, present, and futureAlzheimer's & Dementia, 2026
- Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationJAMA Neurology, 2024
- Subsyndromes and symptom clusters: Multilevel factor analysis of behavioral and psychological symptoms of dementia with intensive longitudinal dataAlzheimer's & Dementia, 2024
- Dementia Subtypes Defined Through Neuropsychiatric Symptom–Associated Brain Connectivity PatternsJAMA Network Open, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Brexpiprazole for the Treatment of Agitation in Alzheimer DementiaJAMA Neurology, 2023
- Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer DiseaseJAMA Network Open, 2023
- Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta‐analysisBrain and Behavior, 2022
- Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related DementiasJAMA Psychiatry, 2022
- Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological studyAlzheimer's & Dementia, 2022